Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Genovis AB (GENO) NPV

Sell:25.50 SEK Buy:25.60 SEK Change: 0.20 SEK (0.78%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:25.50 SEK
Buy:25.60 SEK
Change: 0.20 SEK (0.78%)
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:25.50 SEK
Buy:25.60 SEK
Change: 0.20 SEK (0.78%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Genovis AB is a Sweden-based company engaged in the research and development, production and marketing of technologies and products for cellular research. The Company offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The Company markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.

Contact details

Address:
Medicon Village, Scheelevagen 2
LUND
223 63
Sweden
Telephone:
+46 (46) 101230
Website:
https://www.genovis.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GENO
ISIN:
SE0002485979
Market cap:
1.61 billion SEK
Shares in issue:
63.90 million
Sector:
Life Sciences Tools & Services
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Sarah Fredriksson
    Chairman of the Board
  • Fredrik Olsson
    Chief Executive Officer
  • Johny Humaloja
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Fund and Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.